Both in Pharmaceuticals
Seres Therapeutics vs IGC Pharma
Over the past year MCRB returned −89.5% and IGC returned −40.6%; their daily moves had a correlation of 0.07.
MCRB −89.5% IGC −40.6%Growth of $1, one year, split-adjusted
| Metric | MCRB | IGC |
|---|---|---|
| Price | $1.81 | $0.2492 |
| Market cap | $18.2M | $25.8M |
| Today | −8.59% | −0.28% |
| 1 month | −48.6% | −9.1% |
| 6 months | −74.5% | −20.5% |
| Year to date | −87.8% | −11.4% |
| 1 year | −89.9% | −38.7% |
| Revenue growth (YoY) | — | −19.2% |
| Gross margin | 100.0% | 18.1% |
| Net margin | 622.4% | −1107.9% |
| P/E (TTM) | — | — |
| Price / sales | 9.7× | — |
| Net cash | $15.6M | -$728.0K |
| Dividend yield | — | — |
| Volatility (60d) | 66.5% | 49.5% |
| Short % of float | 4.4% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).